S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
Log in

OTCMKTS:BAYRY - Bayer Stock Price, Forecast & News

$18.78
-0.28 (-1.47 %)
(As of 02/26/2020 04:00 PM ET)
Today's Range
$18.75
Now: $18.78
$19.25
50-Day Range
$18.78
MA: $20.73
$21.59
52-Week Range
$14.61
Now: $18.78
$21.59
Volume466,243 shs
Average Volume392,931 shs
Market Capitalization$70.05 billion
P/E RatioN/A
Dividend Yield2.93%
Beta1.09
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BAYRY
CUSIPN/A
Phone49-21-4-30-1

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$46.75 billion
Cash Flow$3.73 per share
Book Value$14.61 per share

Profitability

Net Income$2.00 billion

Miscellaneous

Employees110,838
Outstanding Shares3,730,204,000
Market Cap$70.05 billion
Next Earnings Date2/26/2020 (Estimated)
OptionableNot Optionable

Receive BAYRY News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter.


Bayer (OTCMKTS:BAYRY) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the OTCMKTS under the ticker symbol "BAYRY."

How were Bayer's earnings last quarter?

Bayer AG (OTCMKTS:BAYRY) released its earnings results on Thursday, October, 29th. The company reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.65 by $0.23. The firm had revenue of $12.28 billion for the quarter, compared to analysts' expectations of $12.79 billion. Bayer had a positive return on equity of 13.42% and a negative net margin of 2.89%. View Bayer's Earnings History.

When is Bayer's next earnings date?

Bayer is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for Bayer.

What is the consensus analysts' recommendation for Bayer?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bayer.

Has Bayer been receiving favorable news coverage?

Press coverage about BAYRY stock has trended somewhat positive on Wednesday, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Bayer earned a news sentiment score of 2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Bayer.

Who are some of Bayer's key competitors?

What other stocks do shareholders of Bayer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bayer investors own include AT&T (T), Exxon Mobil (XOM), Bayer (BAYN), CVS Health (CVS), General Electric (GE), Pfizer (PFE), Gilead Sciences (GILD), Bank of America (BAC), Walt Disney (DIS) and Verizon Communications (VZ).

Who are Bayer's key executives?

Bayer's management team includes the folowing people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 57)
  • Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50)
  • Mr. Liam Condon, Pres of Bayer Crop Science Division & Member of Management Board (Age 51)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 63)

How do I buy shares of Bayer?

Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Bayer's stock price today?

One share of BAYRY stock can currently be purchased for approximately $18.78.

How big of a company is Bayer?

Bayer has a market capitalization of $70.05 billion and generates $46.75 billion in revenue each year. The company earns $2.00 billion in net income (profit) each year or $1.75 on an earnings per share basis. Bayer employs 110,838 workers across the globe.View Additional Information About Bayer.

What is Bayer's official website?

The official website for Bayer is http://www.bayer.com/.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49-21-4-30-1 or via email at [email protected]


MarketBeat Community Rating for Bayer (OTCMKTS BAYRY)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  380 (Vote Outperform)
Underperform Votes:  458 (Vote Underperform)
Total Votes:  838
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel